Wells Fargo’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.26M Buy
236,941
+3,302
+1% +$25.6K ﹤0.01% 3187
2025
Q4
$1.82M Buy
233,639
+100,603
+76% +$727K ﹤0.01% 3521
2025
Q3
$1.01M Sell
133,036
-151,895
-53% -$1.26M ﹤0.01% 3814
2025
Q2
$2.55M Buy
284,931
+66,847
+31% +$623K ﹤0.01% 3025
2025
Q1
$1.64M Buy
218,084
+113,921
+109% +$919K ﹤0.01% 3323
2024
Q4
$783K Buy
104,163
+36,166
+53% +$275K ﹤0.01% 3881
2024
Q3
$517K Sell
67,997
-4,447
-6% -$33.8K ﹤0.01% 3968
2024
Q2
$448K Buy
72,444
+9,787
+16% +$54K ﹤0.01% 3985
2024
Q1
$318K Buy
62,657
+6,818
+12% +$38.3K ﹤0.01% 4181
2023
Q4
$334K Sell
55,839
-136,351
-71% -$790K ﹤0.01% 4142
2023
Q3
$1.36M Sell
192,190
-63,491
-25% -$456K ﹤0.01% 3103
2023
Q2
$1.8M Buy
255,681
+71,732
+39% +$576K ﹤0.01% 2997
2023
Q1
$1.53M Buy
183,949
+174,123
+1,772% +$1.68M ﹤0.01% 3081
2022
Q4
$113K Sell
9,826
-7,421
-43% -$92.5K ﹤0.01% 4478
2022
Q3
$216K Sell
17,247
-5,425
-24% -$69.8K ﹤0.01% 4203
2022
Q2
$240K Sell
22,672
-132,280
-85% -$1.36M ﹤0.01% 4178
2022
Q1
$2.52M Sell
154,952
-61,242
-28% -$982K ﹤0.01% 3073
2021
Q4
$3M Buy
216,194
+15,423
+8% +$204K ﹤0.01% 3095
2021
Q3
$2.89M Sell
200,771
-160
-0.1% -$2.52K ﹤0.01% 3358
2021
Q2
$3.18M Sell
200,931
-868
-0.4% -$11.8K ﹤0.01% 3276
2021
Q1
$2.05M Sell
201,799
-270,578
-57% -$2.79M ﹤0.01% 3669
2020
Q4
$3.52M Buy
472,377
+3,691
+0.8% +$19K ﹤0.01% 3045
2020
Q3
$1.61M Sell
468,686
-11,436
-2% -$49K ﹤0.01% 3486
2020
Q2
$2.29M Buy
480,122
+387,709
+420% +$1.55M ﹤0.01% 3167
2020
Q1
$184K Sell
92,413
-52,306
-36% -$144K ﹤0.01% 4740
2019
Q4
$500K Sell
144,719
-44,863
-24% -$113K ﹤0.01% 4368
2019
Q3
$544K Buy
189,582
+6,163
+3% +$19.2K ﹤0.01% 4313
2019
Q2
$695K Buy
183,419
+98,038
+115% +$590K ﹤0.01% 4152
2019
Q1
$696K Buy
85,381
+19,386
+29% +$166K ﹤0.01% 4141
2018
Q4
$532K Sell
65,995
-1,759
-3% -$13.7K ﹤0.01% 4294
2018
Q3
$517K Buy
67,754
+4,628
+7% +$31.1K ﹤0.01% 4414
2018
Q2
$361K Sell
63,126
-4,926
-7% -$27.1K ﹤0.01% 4688
2018
Q1
$324K Buy
68,052
+15,403
+29% +$79.1K ﹤0.01% 4697
2017
Q4
$258K Sell
52,649
-44,022
-46% -$213K ﹤0.01% 4830
2017
Q3
$507K Buy
96,671
+32,530
+51% +$167K ﹤0.01% 4327
2017
Q2
$356K Sell
64,141
-15,962
-20% -$97.2K ﹤0.01% 4434
2017
Q1
$673K Sell
80,103
-38,330
-32% -$267K ﹤0.01% 4052
2016
Q4
$750K Buy
118,433
+90,103
+318% +$469K ﹤0.01% 3919
2016
Q3
$125K Buy
28,330
+6,500
+30% +$26K ﹤0.01% 4769
2016
Q2
$62K Sell
21,830
-14,578
-40% -$45.3K ﹤0.01% 5110
2016
Q1
$103K Buy
36,408
+4,199
+13% +$18.6K ﹤0.01% 4801
2015
Q4
$332K Sell
32,209
-13,976
-30% -$139K ﹤0.01% 4150
2015
Q3
$526K Sell
46,185
-6,238
-12% -$83.2K ﹤0.01% 3909
2015
Q2
$783K Buy
52,423
+10,767
+26% +$122K ﹤0.01% 3793
2015
Q1
$376K Buy
41,656
+3,428
+9% +$35.5K ﹤0.01% 4116
2014
Q4
$465K Buy
38,228
+5,449
+17% +$60.2K ﹤0.01% 3993
2014
Q3
$321K Buy
32,779
+11,705
+56% +$143K ﹤0.01% 4130
2014
Q2
$269K Sell
21,074
-18,436
-47% -$179K ﹤0.01% 4237
2014
Q1
$418K Buy
39,510
+13,454
+52% +$143K ﹤0.01% 3969
2013
Q4
$198K Sell
26,056
-7,846
-23% -$49.7K ﹤0.01% 4256
2013
Q3
$247K Buy
33,902
+24,751
+270% +$126K ﹤0.01% 4099
2013
Q2
$14K Buy
+9,151
New +$15.8K ﹤0.01% 4967

Other funds holding BCRX